STATCenter·
STAT+: Popular insulin product enters shortage as other pens leave market
The Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.
Read at STAT →
Health · 1 sources covering this
STAT+: Popular insulin product enters shortage as other pens leave market
The Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/2734d1d102de3aa74b84fde9384719476eec75a6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: Popular insulin product enters shortage as other pens leave market"></iframe>
